Gideon E Schreiber

Title: Gideon E Schreiber: Innovator in Recombinant Interferon Research

Introduction

Gideon E Schreiber is a prominent inventor based in Rehovot, Israel. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant interferon therapies. With a total of 3 patents, his work focuses on innovative solutions for treating various diseases.

Latest Patents

One of his latest patents is titled "Recombinant interferon α2 (IFNα2) mutants and methods of use thereof." This invention provides IFNα2 mutants and active fragments, analogs, derivatives, and variants that can be utilized in pharmaceutical compositions for treating cancer, infectious diseases, and autoimmune diseases. Another notable patent is "Nucleic acid molecules encoding recombinant interferon-α2 (IFNα2) mutants." This invention offers IFNα2 mutants with improved specific agonist or antagonist activity compared to wild-type IFNα2, along with pharmaceutical compositions for treating or preventing various diseases.

Career Highlights

Gideon has worked at esteemed institutions such as the Weizmann Institute of Science and Yeda Research and Development Company Ltd. His research has significantly advanced the understanding and application of interferon therapies in medical science.

Collaborations

Throughout his career, Gideon has collaborated with notable colleagues, including Laila C Roisman and Diego Jaitin. These partnerships have contributed to the success and impact of his research.

Conclusion

Gideon E Schreiber's innovative work in recombinant interferon research has paved the way for new therapeutic approaches to combat serious diseases. His contributions continue to influence the field of biotechnology and medicine.